Christine Vieweg

Further involvements

• 21/09/2023

  17:10 – 17:15 3 Min. 2 Min.

  • ePoster
  • PS-3-9

  SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays

   COVID-19
• 21/09/2023

  17:15 – 17:20 3 Min. 2 Min.

  • ePoster
  • PS-3-10

  A randomised open-label trial of early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals

   COVID-19
• 21/09/2023

  17:20 – 17:25 3 Min. 2 Min.

  • ePoster
  • PS-3-11

  Effective neutralizing and cellular immunity against SARS-CoV-2 after mRNA booster vaccination is associated with the activation of B cells and pDCs

   COVID-19